Skip to content

Esophageal adaptation to different textures of food comparing with ages

Esophageal adaptation to different textures of food comparing with ages

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20221025001
Enrollment
60
Registered
2022-10-25
Start date
2022-10-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia Swallowing physiology Esophageal dysphagia Esophageal manometry Esophageal mano-fluoroscopy

Interventions

healthy volunteer,healthy volunteer,healthy volunteer
age 20-40 yr,age 41-60 yr,age 61-80 yr

Sponsors

The Royal College of Physicians of Thailand (RCPT)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age 20-80 years Swallowing disturbance questionnaire (SDQ) score below 0.5 Able to follow commands On a regular diet at home

Exclusion criteria

Exclusion criteria: Unable to communicate and answer the SDQ Uncontrolled medical conditions including unstable vital signs, COPD, or asthma exacerbation The presence of esophageal dysmotility symptoms such as heartburn, chest pain, regurgitation, chronic cough, hoarseness of voice, nausea and vomiting History of disease or disorder that altered esophageal function such as stroke, Parkinsons disease, Alzheimer, motor neuron disease, multiple sclerosis, oropharyngeal anatomical distortion from head and neck cancer, sarcopenia, GERD, and achalasia Chronic disease involving vital organs including heart, brain, kidney, liver, lung, CNT disease, psychiatric problems, severe OSA, poor controlled DM except for HT, DLP BMI less than 18.5 or greater than 25 or weight loss of more than 5 percent over 6 to 12 months History of head and neck surgery, esophageal or gastric surgery Using prokinetics, antispasmodics, muscle relaxants, anti-cholinergic, opioids, nitrate, calcium channel blocker, antidepressant, and beta adrenergic antagonist within 1 week cannot withhold medication during the period of the study

Design outcomes

Primary

MeasureTime frame
Esophageal wall distension at the beginning of study Metric of esophageal manometry

Secondary

MeasureTime frame
Esophageal clearance at the beginning of study FLuoroscopy

Countries

Thailand

Contacts

Public ContactNanicha Siriwong

King Chulalongkorn Memorial Hospital

yambluess14@gmail.com0837190462

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026